Key result
A 34-year-old woman with a triple pregnancy developed peripartum cardiomyopathy and showed rapid clinical improvement with standard heart failure therapy, though mild left ventricular dysfunction persisted.
Why the study?
Peripartum cardiomyopathy is a disease of unknown cause with potentially life-threatening consequences and challenges in diagnosis and treatment.
Case Report (n=1)
No
Answers are grounded in this paper and cite their sources.
Standard therapy may allow rapid recovery in peripartum cardiomyopathy after triplet pregnancy; leaves open predictors of full LV recovery and subsequent pregnancy risk.
Congestive heart failure is an uncommon complication of pregnancy with potentially life-threatening consequences. Peripartum cardiomyopathy (PPCM) is a disease of unknown cause in which severe left ventricular dysfunction occurs during late pregnancy or the early puerperium. In the past, the diagnosis of this entity was made on clinical grounds; however, modern echocardiographic techniques have allowed more accurate diagnoses by excluding cases of diseases that mimic the clinical symptoms and signs of heart failure. Risk factors for peripartum cardiomyopathy include advanced maternal age, multiparity, African descent, twinning, and long-term tocolysis. An extensive search for the causes of peripartum cardiomyopathy has been unrevealing. Treatment does not differ from treatment of idiopathic cardiomyopathy. The prognosis of peripartum cardiomyopathy is related to the recovery of ventricular function. Caution is advised in recommending subsequent pregnancy, especially if left ventricular dysfunction is persistent. In this review, we will discuss different aspects of PPCM as the initial patient contact, obstetricians and family practitioners must recognize this malady early and rapidly institute the proper medical therapy directed towards the congestive state.
No takes yet. Share an insight, caveat, or question.
Alshamiri et al. (2003) conducted a case report in Peripartum cardiomyopathy (n=1). Heart failure therapy (diuretics, digitalis, ACE-I) was evaluated on Left ventricular ejection fraction and clinical symptoms. A 34-year-old woman with a triple pregnancy developed peripartum cardiomyopathy and showed rapid clinical improvement with standard heart failure therapy, though mild left ventricular dysfunction persisted.
Synapse has enriched 10 related papers. Consider them for comparative context: